Notify me when Ho Chi Sing files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| CASI | CASI Pharmaceuticals, Inc. | Ordinary Shares, $0.0001 par value | 6.4% | $2M | 993K | Quan Zhou | 30 Dec 2024 | ||
| PONY | Pony AI Inc. | Class A ordinary shares, par value US$0.0005 per share | 4.3% | $344M | -$66.9M | 15.3M | -16.3% | IDG China Venture Capital Fund IV L.P. | 30 Sep 2025 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|